日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Targeted β(-)-Particle Plus Conversion and Auger-Electron Therapy with (161)Tb-Labeled Somatostatin Receptor Antagonist DOTA-LM3: A Phase 0 Study

使用 (161)Tb 标记的生长抑素受体拮抗剂 DOTA-LM3 进行靶向 β(-) 粒子增强转化和俄歇电子疗法：一项 0 期研究

期刊:
影响因子:
doi:10.2967/jnumed.125.270654
Fricke, Julia G; Westerbergh, Frida; McDougall, Lisa; Favaretto, Chiara; Christ, Emanuel; Nicolas, Guillaume P; Geistlich, Susanne; Schmid, David E; Borgna, Francesca; Fani, Melpomeni; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Schibli, Roger; Wild, Damian
信号转导
发表日期：2026
文献求助 收藏

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([(161)Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum

首次在人体中应用铽-161标记的生长抑素受体2亚型拮抗剂（[(161)Tb]Tb-DOTA-LM3）治疗回肠转移性神经内分泌肿瘤患者

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06641-w
Fricke, Julia; Westerbergh, Frida; McDougall, Lisa; Favaretto, Chiara; Christ, Emanuel; Nicolas, Guillaume P; Geistlich, Susanne; Borgna, Francesca; Fani, Melpomeni; Bernhardt, Peter; van der Meulen, Nicholas P; Müller, Cristina; Schibli, Roger; Wild, Damian
信号转导
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.

设计和临床前评估一种新型前列腺特异性膜抗原放射性配体，该配体经转甲状腺素结合剂修饰

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16071262
Vaccarin Christian, Mapanao Ana Katrina, Deberle Luisa M, Becker Anna E, Borgna Francesca, Marzaro Giovanni, Schibli Roger, Müller Cristina
其它
发表日期：2024
文献求助 收藏

Impact of the mouse model and molar amount of injected ligand on the tissue distribution profile of PSMA radioligands

小鼠模型和注射配体的摩尔量对PSMA放射性配体组织分布的影响

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-021-05446-5
Tschan, Viviane J; Borgna, Francesca; Schibli, Roger; Müller, Cristina
发表日期：2022
文献求助 收藏

Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms

铽-161与生长抑素受体拮抗剂联合应用——神经内分泌肿瘤治疗的潜在范式转变

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-021-05564-0
Borgna, Francesca; Haller, Stephanie; Rodriguez, Josep M Monné; Ginj, Mihaela; Grundler, Pascal V; Zeevaart, Jan Rijn; Köster, Ulli; Schibli, Roger; van der Meulen, Nicholas P; Müller, Cristina
信号转导
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Preclinical investigations using [(177)Lu]Lu-Ibu-DAB-PSMA toward its clinical translation for radioligand therapy of prostate cancer

利用[(177)Lu]Lu-Ibu-DAB-PSMA进行临床前研究，以期将其转化为前列腺癌放射性配体疗法。

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-022-05837-2
Tschan, Viviane J; Borgna, Francesca; Busslinger, Sarah D; Stirn, Martina; Rodriguez, Josep M Monné; Bernhardt, Peter; Schibli, Roger; Müller, Cristina
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Simultaneous Visualization of (161)Tb- and (177)Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging

利用双同位素SPECT成像技术同时可视化(161)Tb和(177)Lu标记的生长抑素类似物

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics13040536
Borgna, Francesca; Barritt, Patrick; Grundler, Pascal V; Talip, Zeynep; Cohrs, Susan; Zeevaart, Jan Rijn; Köster, Ulli; Schibli, Roger; van der Meulen, Nicholas P; Müller, Cristina
发表日期：2021
文献求助 收藏

Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations

大规模分离制备铒-169：迈向首次临床前体外研究

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2021.643175
Talip, Zeynep; Borgna, Francesca; Müller, Cristina; Ulrich, Jiri; Duchemin, Charlotte; Ramos, Joao P; Stora, Thierry; Köster, Ulli; Nedjadi, Youcef; Gadelshin, Vadim; Fedosseev, Valentin N; Juget, Frederic; Bailat, Claude; Fankhauser, Adelheid; Wilkins, Shane G; Lambert, Laura; Marsh, Bruce; Fedorov, Dmitry; Chevallay, Eric; Fernier, Pascal; Schibli, Roger; van der Meulen, Nicholas P
发表日期：2021
文献求助 收藏

Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity

开发一类新型PSMA放射性配体，该配体包含布洛芬作为白蛋白结合实体

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.40482
Deberle, Luisa M; Benešová, Martina; Umbricht, Christoph A; Borgna, Francesca; Büchler, Manuel; Zhernosekov, Konstantin; Schibli, Roger; Müller, Cristina
发表日期：2020
文献求助 收藏

Albumin-Binding PSMA Radioligands: Impact of Minimal Structural Changes on the Tissue Distribution Profile

白蛋白结合PSMA放射性配体：微小结构变化对组织分布的影响

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules25112542
Deberle, Luisa M; Tschan, Viviane J; Borgna, Francesca; Sozzi-Guo, Fan; Bernhardt, Peter; Schibli, Roger; Müller, Cristina
发表日期：2020
文献求助 收藏